V009-1143 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-[1-(3-bromophenyl)-N-(3-methoxypropyl)formamido]-N-[(3-methylthiophen-2-yl)methyl]acetamide

V009-1143 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-[1-(3-bromophenyl)-N-(3-methoxypropyl)formamido]-N-[(3-methylthiophen-2-yl)methyl]acetamide
V009-1143 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-[1-(3-bromophenyl)-N-(3-methoxypropyl)formamido]-N-[(3-methylthiophen-2-yl)methyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V009-1143
N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-[1-(3-bromophenyl)-N-(3-methoxypropyl)formamido]-N-[(3-methylthiophen-2-yl)methyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V009-1143

Molecular Formula

C27H29BrN2O5S (C27 H29 BrN2 O5 S)

Compound Name

N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-[1-(3-bromophenyl)-N-(3-methoxypropyl)formamido]-N-[(3-methylthiophen-2-yl)methyl]acetamide

IUPAC name

N-[(2H-13-benzodioxol-5-yl)methyl]-2-[1-(3-bromophenyl)-N-(3-methoxypropyl)formamido]-N-[(3-methylthiophen-2-yl)methyl]acetamide

SMILES

Cc1c(CN(Cc(cc2)cc3c2OCO3)C(CN(CCCOC)C(c2cccc(Br)c2)=O)=O)scc1

InChI

InChI=1S/C27H29BrN2O5S/c1-19-9-12-36-25(19)16-30(15-20-7-8-23-24(13-20)35-18-34-23)26(31)17-29(10-4-11-33-2)27(32)21-5-3-6-22(28)14-21/h3,5-9,12-14H,4,10-11,15-18H2,1-2H3

InChI Key

DITAXGSMHNRMSP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19771396

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

573.51

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.684

Distribution Coefficient, logD

4.684

Water Solubility, LogSw

-4.51

Polar Surface Area

58.588

Acid Dissociation Constant (pKa)

21.47

Base Dissociation Constant (pKb)

-1.45

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

V009-1143 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

Anticancer Library (62698 compounds)

SH2 Library (10483 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Cancer
  • Endocrine
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with V009-1143 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V009-1143?
Check Price and Availability of V009-1143, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V009-1143 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V009-1143
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V009-1143
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V009-1143 available by request